1 – 49 of 49
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
The impact of immunomodulating treatment on the immunogenicity of COVID-19 vaccines in patients with immune-mediated inflammatory rheumatic diseases compared to healthy controls. A Swedish nationwide study (COVID19-REUMA)
(
- Contribution to journal › Article
-
Mark
Reduced risk of serious pneumococcal infections up to 10 years after a dose of pneumococcal conjugate vaccine in established arthritis.
(
- Contribution to journal › Article
- 2017
-
Mark
Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza
(
- Contribution to journal › Article
- 2016
-
Mark
Human Papillomavirus neutralizing and cross-reactive antibodies induced in HIV-positive subjects after vaccination with quadrivalent and bivalent HPV vaccines.
(
- Contribution to journal › Article
- 2015
-
Mark
Two consecutive randomized controlled pertussis booster trials in children initially vaccinated in infancy with an acellular vaccine: The first with a five-component Tdap vaccine to 5-year olds and the second with five- or monocomponent Tdap vaccines at age 14-15 years.
(
- Contribution to journal › Article
-
Mark
Immune responses following meningococcal serogroups A, C, Y and W polysaccharide vaccination in C2-deficient persons: Evidence for increased levels of serum bactericidal antibodies.
(
- Contribution to journal › Article
- 2014
-
Mark
Impact of immunization with Protein F on pulmonary clearance of nontypeable Haemophilus influenzae.
(
- Contribution to journal › Article
-
Mark
Parental attitudes and decision-making regarding MMR vaccination in an anthroposophic community in Sweden – A qualitative study
(
- Contribution to journal › Article
- 2013
-
Mark
13-Valent pneumococcal conjugate vaccine (PCV13) in children partially immunized with 7-valent pneumococcal conjugate vaccine (PCV7): A phase 3, open-label trial
(
- Contribution to journal › Article
-
Mark
The immunological effect of revaccination with Bacille Calmette-Guerin vaccine at 19 months of age
(
- Contribution to journal › Article
-
Mark
Pre-vaccination seroprevalence of 15 human papillomavirus (HPV) types among women in the population-based Slovenian cervical screening program
(
- Contribution to journal › Article
- 2012
-
Mark
A tetravalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine is immunogenic and well-tolerated when co-administered with Twinrix (R) in subjects aged 11-17 years: An open, randomised, controlled trial
(
- Contribution to journal › Article
-
Mark
International collaborative proficiency study of Human Papillomavirus type 16 serology.
(
- Contribution to journal › Article
- 2011
-
Mark
The factor H-binding fragment of PspC as a vaccine antigen for the induction of protective humoral immunity against experimental pneumococcal sepsis
(
- Contribution to journal › Article
-
Mark
Prevalence of antibodies against Kaposi's sarcoma associated herpes virus (KSHV) complement inhibitory protein (KCP) in KSHV-related diseases and their correlation with clinical parameters.
(
- Contribution to journal › Article
-
Mark
Temporal development of the humoral immune response to surface antigens of Moraxella catarrhalis in young infants
(
- Contribution to journal › Article
- 2010
-
Mark
Immunomodulatory nanoparticles as adjuvants and allergen-delivery system to human dendritic cells: Implications for specific immunotherapy.
(
- Contribution to journal › Article
-
Mark
Tracking parental attitudes on vaccination across European countries: The Vaccine Safety, Attitudes, Training and Communication Project (VACSATC)
(
- Contribution to journal › Article
-
Mark
Immunization with the recombinant Burkholderia pseudomallei outer membrane protein Omp85 induces protective immunity in mice
(
- Contribution to journal › Article
- 2009
-
Mark
Surveillance of Vaccine Safety: Comparison of parental reports with routine surveillance and a clinical trial
(
- Contribution to journal › Article
-
Mark
Risk of lymphoma and leukaemia after bacille Calmette-Guerin and smallpox vaccination: A Danish case-cohort study
(
- Contribution to journal › Article
-
Mark
Neutralizing activity and cellular immune responses induced in mice after immunization with apoptotic HIV-1/murine leukemia virus infected cells
(
- Contribution to journal › Article
-
Mark
Prevention of otitis media: Now a reality?
(
- Contribution to journal › Scientific review
- 2008
-
Mark
Effects of a large-scale introduction of the pneumococcal polysaccharide vaccine among elderly persons in Stockholm, Sweden
(
- Contribution to journal › Article
-
Mark
Species-specificity of Neisseria gonorrhoeae infection: Do human complement regulators contribute?
(
- Contribution to journal › Article
-
Mark
HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine
(
- Contribution to journal › Article
-
Mark
Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing Countries
(
- Contribution to journal › Article
-
Mark
Global HIV Vaccine Research Cryorepository - GHRC
(
- Contribution to journal › Published meeting abstract
-
Mark
Seroepidemiology as basis for design of a human papillomavirus vaccination program.
(
- Contribution to journal › Article
-
Mark
Contribution of interactions between complement inhibitor C4b-binding protein and pathogens to their ability to establish infection with particular emphasis on Neisseria gonorrhoeae.
(
- Contribution to journal › Article
- 2007
-
Mark
Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine
(
- Contribution to journal › Article
-
Mark
Antibodies against Kaposi sarcoma-associated herpes virus (KSHV) complement control protein (KCP) in infected individuals
(
- Contribution to journal › Article
-
Mark
Humoral immunity targeting site I of antigenic domain 2 of glycoprotein B upon immunization with different cytomegalovirus candidate vaccines.
(
- Contribution to journal › Article
-
Mark
Children exposed to environmental smoking have a higher antibiotic consumption.
(
- Contribution to journal › Article
-
Mark
A non-beneficial effect of BCG on non-tuberculous childhood mortality?
(
- Contribution to journal › Letter
-
Mark
Human antibody response towards the pneumococcal surface proteins PspA and PspC during invasive pneumococcal infection.
(
- Contribution to journal › Article
- 2006
-
Mark
Pandemic influenza preparedness: The critical role of the syringe
(
- Contribution to journal › Article
-
Mark
Clinical applications of HPV testing: A summary of meta-analyses
(
- Contribution to journal › Article
-
Mark
Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18
(
- Contribution to journal › Article
-
Mark
Studies to assess the long-term efficacy and effectiveness of HPV vaccination in developed and developing countries
(
- Contribution to journal › Article
-
Mark
International Standard reagents for harmonization of HPV serology and DNA assays - an update
(
- Contribution to journal › Article
-
Mark
Vaccinia scars associated with better survival for adults. An observational study from Guinea-Bissau
(
- Contribution to journal › Article
- 2005
-
Mark
Reactogenicity and immunogenicity profile of a two-dose combined hepatitis A and B vaccine in 1-11-year-old children
(
- Contribution to journal › Article
-
Mark
Vaccination technique, PPD reaction and BCG scarring in a cohort of children born in Guinea-Bissau 2000-2002
(
- Contribution to journal › Article
- 2004
-
Mark
Persistent itching nodules after the fourth dose of diphtheria-tetanus toxoid vaccines without evidence of delayed hypersensitivity to aluminium
(
- Contribution to journal › Article
-
Mark
Identification and assessment of new vaccine candidates for group A streptococcal infections.
(
- Contribution to journal › Article
-
Mark
A liquid hexavalent combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, Haemophilus influenzae type B and hepatitis B: review of immunogenicity and safety
(
- Contribution to journal › Scientific review
-
Mark
Host-pathogen interactions in Streptococcus pyogenes infections, with special reference to puerperal fever and a comment on vaccine development.
(
- Contribution to journal › Article
- 2003
-
Mark
BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa. A non-specific beneficial effect of BCG?
(
- Contribution to journal › Article